A finished medicine
A product with FDA approval
FDA stands for Food and Drug Administration, a US agency whose work includes reviewing medicines.
Semaglutide is the medicine ingredient in Ozempic and Wegovy. Tirzepatide is the ingredient in Mounjaro and Zepbound.
In FDA records as of September 2026, Ozempic (semaglutide) and Mounjaro (tirzepatide) are listed to help control blood sugar with type 2 diabetes.
As of September 2026, FDA approval covers weight loss or weight control with Wegovy (semaglutide) and Zepbound (tirzepatide).
An approval covers one specific medicine for a specific use. Ask which use matches the reason you are seeking care.